AM-111 in the Treatment of Acute Inner Ear Hearing Loss
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the effectiveness and safety of the study drug,
AM-111. AM-111 is tested for the treatment of sudden sensorineural hearing loss where the
cause is unknown.